
Updates on Glucagon-Like Peptide-1 Receptor Agonists for Diabetes and Obesity
Published: | Updated:
Higher doses of injectable semaglutide have been shown to cause greater weight loss than standard doses with a similar safety profile.

Higher doses of injectable semaglutide have been shown to cause greater weight loss than standard doses with a similar safety profile.

Published: November 20th 2026 | Updated: November 30th 2026